Literature DB >> 21917874

Short-term energy deprivation alters activin a and follistatin but not inhibin B levels of lean healthy women in a leptin-independent manner.

Vasiliki A Moragianni1, Konstantinos N Aronis, John P Chamberland, Christos S Mantzoros.   

Abstract

CONTEXT: Leptin is a potent modulator of the hypothalamic-pituitary-gonadal axis mediating the effect of energy deprivation on several hypothalamic-pituitary-peripheral axes. Activin A, inhibin B, and follistatin (FST) also regulate the hypothalamic-pituitary-gonadal axis in humans. It remains unknown whether energy deprivation affects these hormone levels in a leptin-dependent or -independent manner.
OBJECTIVE: We investigated 1) day-night variability patterns of activin, inhibin, and FST in the fed state, 2) whether their levels are affected by fasting, and 3) whether such an effect is mediated by leptin in physiological replacement or pharmacological doses.
DESIGN: We conducted two studies in healthy, eumenorrheic females, each comprising three separate admissions. In study 1, six women were maintained for 72 h 1) on isocaloric diet, 2) fasting while receiving placebo, or 3) fasting while receiving metreleptin in physiological replacement doses. In study 2, five women were administered physiological or pharmacological metreleptin doses (0.01, 0.1, or 0.3 mg/kg i.v. four times daily).
RESULTS: Neither activin A nor FST had a pulsatile or day-night variability pattern. Inhibin B levels were also nonpulsatile, but a trend toward a day-night pattern was noted. When compared with the fed state, inhibin B levels remained unchanged, whereas FST levels increased (P = 0.01) and activin A decreased (P = 0.01) in the fasting state. These changes were not corrected with metreleptin administered in replacement or pharmacological doses.
CONCLUSIONS: Short-term energy deprivation alters levels of activin A and FST, but these effects are not mediated by leptin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917874      PMCID: PMC3232616          DOI: 10.1210/jc.2011-1453

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  59 in total

1.  Inhibin B: a potential marker of gonadal activity in patients with anorexia nervosa during weight recovery.

Authors:  Vera Popovic; Marina Djurovic; Aleksandar Cetkovic; Danilo Vojvodic; Sandra Pekic; Svetlana Spremovic; Milan Petakov; Svetozar Damjanovic; Natasa Milic; Carlo Dieguez; Felipe F Casanueva
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

2.  Fasting-induced changes in ovulation rate, plasma leptin, gonadotropins, GH, IGF-I and insulin concentrations during oestrus in ewes.

Authors:  U Kosior-Korzecka; R Bobowiec; Cz Lipecka
Journal:  J Vet Med A Physiol Pathol Clin Med       Date:  2006-02

Review 3.  Chemical and biological characterization of the inhibin family of protein hormones.

Authors:  W Vale; C Rivier; A Hsueh; C Campen; H Meunier; T Bicsak; J Vaughan; A Corrigan; W Bardin; P Sawchenko
Journal:  Recent Prog Horm Res       Date:  1988

Review 4.  Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa.

Authors:  Jean L Chan; Christos S Mantzoros
Journal:  Lancet       Date:  2005 Jul 2-8       Impact factor: 79.321

5.  Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.

Authors:  Elizabeth Sienkiewicz; Faidon Magkos; Konstantinos N Aronis; Mary Brinkoetter; John P Chamberland; Sharon Chou; Kalliopi M Arampatzi; Chuanyun Gao; Anastasia Koniaris; Christos S Mantzoros
Journal:  Metabolism       Date:  2011-07-07       Impact factor: 8.694

6.  Development of a second generation Inhibin B ELISA.

Authors:  Bhanu Kalra; Ajay Kumar; Kinita Patel; Amita Patel; M J Khosravi
Journal:  J Immunol Methods       Date:  2010-08-21       Impact factor: 2.303

7.  Ultradian oscillations of leptin secretion in humans.

Authors:  M K Sinha; J Sturis; J Ohannesian; S Magosin; T Stephens; M L Heiman; K S Polonsky; J F Caro
Journal:  Biochem Biophys Res Commun       Date:  1996-11-21       Impact factor: 3.575

Review 8.  Leptin in humans: lessons from translational research.

Authors:  Susann Blüher; Christos S Mantzoros
Journal:  Am J Clin Nutr       Date:  2009-01-28       Impact factor: 7.045

Review 9.  Regulation of ovarian function by the TGF-beta superfamily and follistatin.

Authors:  Shyr-Yeu Lin; John R Morrison; David J Phillips; David M de Kretser
Journal:  Reproduction       Date:  2003-08       Impact factor: 3.906

10.  Reduced gonadotropin-releasing hormone gene expression with fasting in the male rat brain.

Authors:  D A Gruenewald; A M Matsumoto
Journal:  Endocrinology       Date:  1993-01       Impact factor: 4.736

View more
  7 in total

1.  Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.

Authors:  Stergios A Polyzos; Nikolaos Perakakis; Chrysoula Boutari; Jannis Kountouras; Wael Ghaly; Athanasios D Anastasilakis; Asterios Karagiannis; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

2.  The Role of Leptin in Maintaining Plasma Glucose During Starvation.

Authors:  Rachel J Perry; Gerald I Shulman
Journal:  Postdoc J       Date:  2018-03

3.  FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.

Authors:  Joo Young Huh; Grigorios Panagiotou; Vassilis Mougios; Mary Brinkoetter; Maria T Vamvini; Benjamin E Schneider; Christos S Mantzoros
Journal:  Metabolism       Date:  2012-09-25       Impact factor: 8.694

4.  Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function.

Authors:  Nikolaos Perakakis; Jagriti Upadhyay; Wael Ghaly; Joyce Chen; Pavlina Chrysafi; Athanasios D Anastasilakis; Christos S Mantzoros
Journal:  Metabolism       Date:  2018-05-09       Impact factor: 8.694

5.  Activin A and follistatin in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Athanasios D Anastasilakis; Georgios Α Triantafyllou; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-07-25       Impact factor: 8.694

6.  Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans.

Authors:  Athanasios D Anastasilakis; Stergios A Polyzos; Elpida C Skouvaklidou; Georgios Kynigopoulos; Zacharias G Saridakis; Aggeliki Apostolou; Georgios A Triantafyllou; Thomai Karagiozoglou-Lampoudi; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-07-08       Impact factor: 8.694

7.  In patients with anorexia nervosa, myokine levels are altered but are not associated with bone mineral density loss and bone turnover alteration.

Authors:  Laurent Maïmoun; Denis Mariano-Goulart; Helena Huguet; Eric Renard; Patrick Lefebvre; Marie-Christine Picot; Anne-Marie Dupuy; Jean-Paul Cristol; Philippe Courtet; Vincent Boudousq; Antoine Avignon; Sébastien Guillaume; Ariane Sultan
Journal:  Endocr Connect       Date:  2022-05-10       Impact factor: 3.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.